JP2000505044A - アスコマイシン類 - Google Patents

アスコマイシン類

Info

Publication number
JP2000505044A
JP2000505044A JP8529996A JP52999696A JP2000505044A JP 2000505044 A JP2000505044 A JP 2000505044A JP 8529996 A JP8529996 A JP 8529996A JP 52999696 A JP52999696 A JP 52999696A JP 2000505044 A JP2000505044 A JP 2000505044A
Authority
JP
Japan
Prior art keywords
compound
formula
carboxy
ascomycin
acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8529996A
Other languages
English (en)
Japanese (ja)
Inventor
ヘルスペルガー，レネ
ネーフ，レト
Original Assignee
ノバルティス・アクチエンゲゼルシャフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9507128.8A external-priority patent/GB9507128D0/en
Priority claimed from GBGB9526049.3A external-priority patent/GB9526049D0/en
Priority claimed from GBGB9526050.1A external-priority patent/GB9526050D0/en
Application filed by ノバルティス・アクチエンゲゼルシャフト filed Critical ノバルティス・アクチエンゲゼルシャフト
Publication of JP2000505044A publication Critical patent/JP2000505044A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
JP8529996A 1995-04-06 1996-04-04 アスコマイシン類 Pending JP2000505044A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB9507128.8 1995-04-06
GBGB9507128.8A GB9507128D0 (en) 1995-04-06 1995-04-06 Organic compounds
GB9526049.3 1995-12-20
GBGB9526049.3A GB9526049D0 (en) 1995-12-20 1995-12-20 Organic compounds
GBGB9526050.1A GB9526050D0 (en) 1995-12-20 1995-12-20 Organic compounds
GB9526050.1 1995-12-20
PCT/EP1996/001492 WO1996031514A1 (fr) 1995-04-06 1996-04-04 Ascomycines

Publications (1)

Publication Number Publication Date
JP2000505044A true JP2000505044A (ja) 2000-04-25

Family

ID=27267660

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8529996A Pending JP2000505044A (ja) 1995-04-06 1996-04-04 アスコマイシン類

Country Status (21)

Country Link
US (1) US5925649A (fr)
EP (1) EP0819130A1 (fr)
JP (1) JP2000505044A (fr)
KR (1) KR19980703583A (fr)
CN (1) CN1088068C (fr)
AR (1) AR004480A1 (fr)
AU (1) AU703523B2 (fr)
BR (1) BR9604808A (fr)
CA (1) CA2216562A1 (fr)
CO (1) CO4750668A1 (fr)
CZ (1) CZ312397A3 (fr)
FI (1) FI973529A7 (fr)
HU (1) HUP9801993A3 (fr)
IL (1) IL117815A (fr)
MX (1) MX9707636A (fr)
NO (1) NO309273B1 (fr)
NZ (1) NZ307170A (fr)
PL (1) PL322553A1 (fr)
SK (1) SK133997A3 (fr)
TR (1) TR199700999T1 (fr)
WO (1) WO1996031514A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006522007A (ja) * 2002-11-15 2006-09-28 ノバルティス アクチエンゲゼルシャフト ドラッグ・デリバリー・システム

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME00189B (me) 1998-03-26 2011-02-10 Astellas Pharma Inc Preparati sa neprekidnim oslobađanjem
CA2326222C (fr) * 1998-04-27 2008-09-23 Fujisawa Pharmaceutical Co., Ltd. Compositions medicinales
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
US6121257A (en) * 1999-03-31 2000-09-19 Abbott Laboratories Sulfamate containing macrocyclic immunomodulators
WO2000066122A1 (fr) * 1999-04-30 2000-11-09 Sucampo Ag Utilisation de composes macrolides pour le traitement des yeux secs
US7063857B1 (en) 1999-04-30 2006-06-20 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
US6593292B1 (en) 1999-08-24 2003-07-15 Cellgate, Inc. Compositions and methods for enhancing drug delivery across and into epithelial tissues
AR033151A1 (es) * 2001-04-12 2003-12-03 Sucampo Pharmaceuticals Inc Agente para el tratamiento oftalmico topico de las enfermedades inflamatorias oculares
BR0209474A (pt) * 2001-05-09 2006-02-07 Novartis Ag Métodos para imunomodulação seletiva
TWI324925B (en) * 2001-08-23 2010-05-21 Novartis Ag Ophthalmic composition
EP1594484A2 (fr) * 2003-02-17 2005-11-16 Cipla Ltd. Composition pharmaceutique
TWI324604B (en) 2003-06-18 2010-05-11 Novartis Ag New use of staurosporine derivatives
US7780973B2 (en) * 2003-12-15 2010-08-24 Ethicon Endo-Surgery, Inc. Method and device for minimally invasive implantation of biomaterial
JP2007516951A (ja) * 2003-12-30 2007-06-28 アステラス製薬株式会社 気道閉塞症の治療または予防のためのマクロライドの使用
US20050142161A1 (en) * 2003-12-30 2005-06-30 Freeman Lynetta J. Collagen matrix for soft tissue augmentation
US20080233053A1 (en) * 2005-02-07 2008-09-25 Pharmalight Inc. Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
US10143682B2 (en) 2014-10-28 2018-12-04 Koushi Yamaguchi Medicine for improving state of pregnancy, and use thereof
US20210228551A1 (en) 2018-08-10 2021-07-29 Koushi Yamaguchi Therapeutic agent for humoral immunity-related diseases in maternofetal relationship
CN120053439A (zh) 2018-12-18 2025-05-30 山口晃史 用于改善不孕不育症或妊娠状态的药物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3244592A (en) * 1962-06-09 1966-04-05 Arai Tadashi Ascomycin and process for its production
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
JPS6317884A (ja) * 1986-05-30 1988-01-25 Fujisawa Pharmaceut Co Ltd トリシクロ化合物
JPH01125394A (ja) * 1987-11-10 1989-05-17 Mect Corp シアロシルグリセロリピッド類及びその製造方法
WO1989005304A1 (fr) * 1987-12-09 1989-06-15 Fisons Plc Composes macrocycliques
WO1991002736A1 (fr) * 1989-08-18 1991-03-07 Fisons Plc Composes macrocycliques
KR0159766B1 (ko) * 1989-10-16 1998-12-01 후지사와 토모키치로 양모제 조성물
DK0427680T3 (da) * 1989-11-09 1995-12-18 Sandoz Ltd Heteroatom-holdige cykliske forbindelser
WO1991013899A1 (fr) * 1990-03-12 1991-09-19 Fujisawa Pharmaceutical Co., Ltd. Composes tricyclo
JPH05507915A (ja) * 1990-06-11 1993-11-11 藤沢薬品工業株式会社 特発性血小板減少性紫斑病およびバセドウ病治療薬製造のためのｆｋ５０６等のマクロライド化合物の用途
MY110418A (en) * 1990-07-02 1998-05-30 Novartis Ag Heteroatoms-containing tricyclic compounds.
ES2099112T3 (es) * 1990-09-04 1997-05-16 Fujisawa Pharmaceutical Co Pomadas que contienen un compuesto triciclico.
CA2054983A1 (fr) * 1990-11-08 1992-05-09 Sotoo Asakura Composition suspensible et procede de fabrication
US5208241A (en) * 1991-09-09 1993-05-04 Merck & Co., Inc. N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
US5252732A (en) * 1991-09-09 1993-10-12 Merck & Co., Inc. D-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity
US5247076A (en) * 1991-09-09 1993-09-21 Merck & Co., Inc. Imidazolidyl macrolides having immunosuppressive activity
US5457194A (en) * 1993-03-17 1995-10-10 Abbott Laboratories Substituted aliphatic amine-containing macrocyclic immunomodulators
CN100335063C (zh) * 1994-10-26 2007-09-05 诺瓦蒂斯有限公司 药物组合物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006522007A (ja) * 2002-11-15 2006-09-28 ノバルティス アクチエンゲゼルシャフト ドラッグ・デリバリー・システム

Also Published As

Publication number Publication date
HUP9801993A3 (en) 2000-04-28
FI973529L (fi) 1997-11-25
HUP9801993A2 (hu) 1998-12-28
CZ312397A3 (cs) 1998-01-14
CO4750668A1 (es) 1999-03-31
CN1180359A (zh) 1998-04-29
CA2216562A1 (fr) 1996-10-10
NO974536D0 (no) 1997-10-01
TR199700999T1 (xx) 1998-01-21
IL117815A0 (en) 1996-08-04
FI973529A7 (fi) 1997-11-25
WO1996031514A1 (fr) 1996-10-10
NZ307170A (en) 1999-03-29
US5925649A (en) 1999-07-20
EP0819130A1 (fr) 1998-01-21
AR004480A1 (es) 1998-12-16
FI973529A0 (fi) 1997-08-27
NO974536L (no) 1997-10-01
BR9604808A (pt) 1998-06-09
AU5645396A (en) 1996-10-23
NO309273B1 (no) 2001-01-08
MX9707636A (es) 1998-06-30
PL322553A1 (en) 1998-02-02
AU703523B2 (en) 1999-03-25
KR19980703583A (ko) 1998-11-05
CN1088068C (zh) 2002-07-24
IL117815A (en) 2000-07-16
SK133997A3 (en) 1998-05-06

Similar Documents

Publication Publication Date Title
JP2000505044A (ja) アスコマイシン類
US5486523A (en) Carbamates of rapamycin
US20060247216A1 (en) Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
AU2006259604A1 (en) Substituted phenylphosphates as mutual prodrugs of steroids and beta -agonists for the treatment of pulmonary inflammation and bronchoconstriction
CZ285421B6 (cs) Nové cyklosporiny
WO2005063777A1 (fr) Promedicaments de benzylphosphate et de benzylphosphate substitue utilises dans le traitement d'une inflammation pulmonaire
CZ287877B6 (cs) Prednisolonové deriváty a farmaceutické prostředky s jejich obsahem
EP4483876A1 (fr) Utilisation d'un composé d'indazole destiné au traitement du psoriasis
HU225567B1 (en) 1,3-dioxo-6-(3-methylaminopropyl)-1,2,3,6-tetrahydro-4-(thiophen-3-yl)-pyrrolo[3,4-c]carbazole, pharmaceutical composition containing it and its use
EP1778709B1 (fr) Glycosides polysulfates et leurs sels
US20220362259A1 (en) Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors
CN113330020B (zh) 用于治疗神经变性疾病的2-氟代的胆汁酸
US9458187B2 (en) Methods for treatment of inflammatory conditions using S-[4-(3-fleuro-3-methylbutyryloxy)but-2-ynyl]6α, 9α-difluoro-17α-(furan-2-yl) carbonyloxy-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carbothioate
EP0470995A1 (fr) Utilisation de composes steroidiques sous forme d'agents antifongiques.
RU2173688C2 (ru) Аскомицины, способ их получения и фармацевтическая композиция на их основе
US20070149583A1 (en) Diazonamide a analog
EP0863873A1 (fr) Indole-carbamates comme antagonistes de leukotriene
HK40062202B (en) 2-fluorinated bile acids for the treatment of neurodegenerative diseases
HK40062202A (en) 2-fluorinated bile acids for the treatment of neurodegenerative diseases
JP2014091677A (ja) キチナーゼ阻害剤
HK1051490A1 (en) Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs